Kimia Biosciences (BOM:530313) Total Assets : ₹0.00 Mil (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Total Assets?

Kimia Biosciences's Total Assets for the quarter that ended in . 20 was ₹0.00 Mil.

Total Assets is connected with ROA %. Kimia Biosciences's annualized ROA % for the quarter that ended in . 20 was %. Total Assets is also linked to Revenue through Asset Turnover. Kimia Biosciences's Asset Turnover for the quarter that ended in . 20 was .

Kimia Biosciences Total Assets Historical Data

The historical data trend for Kimia Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Total Assets Chart

Kimia Biosciences Annual Data

Trend

Total Assets

Kimia Biosciences Semi-Annual Data

Total Assets

Kimia Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kimia Biosciences's Total Assets for the fiscal year that ended in . 20 is calculated as

Total Assets	=	Total Equity (A: . 20 )	+	Total Liabilities (A: . 20 )
	=	N/A	+	N/A
	=	N/A

Kimia Biosciences's Total Assets for the quarter that ended in . 20 is calculated as

Total Assets	=	Total Equity (Q: . 20 )	+	Total Liabilities (Q: . 20 )
	=	N/A	+	N/A
	=	N/A

Kimia Biosciences (BOM:530313) Total Assets Explanation

Total Assets is connected with ROA %.

Kimia Biosciences's annualized ROA % for the quarter that ended in . 20 is

ROA %	=	Net Income (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
	=		/	( (	+	)	/ )
	=		/
	=	%

Note: The Net Income data used here is one times the annual (. 20) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kimia Biosciences's Asset Turnover for the quarter that ended in . 20 is

	Asset Turnover
=	Revenue (Q: . 20 )	/	( (Total Assets (Q: . 20 )	+	Total Assets (Q: . 20 ))	/ count )
=		/	( (	+	)	/ )
=		/
=

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kimia Biosciences Total Assets Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines